EUCTR2014-004078-40-AT进行中（未招募）1 期
A Prospective, Single Center, Observational Study to Assess the Performance, Safety, and Patient Reported Outcomes of Insulin Delivery with PaQ® in Patients with Type 2 Diabetes Mellitus
CeQur Corp.0 个研究点开始时间: 2014年12月22日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Is at least 18 years of age;
- •2.Has a clinical diagnosis of T2DM, as determined by clinical history and medication usage;
- •3.Has an A1C = 7.0% and ? 11.0%;
- •4.Is treated with basal-bolus insulin therapy (at least 2 injections per day) with or without OADs, and/or GLP-1 agonist for at least 3 months and has not had a change (addition or discontinuation of existing drug or change in dose) in their OADs for the last 8 weeks, (See Section 7.4 for definition of baseline basal bolus therapy);
- •5.Determined by the investigator that insulin requirements to achieve glycemic targets can be met by the insulin capacity of the PaQ device;
- •6.If on concomitant metformin, has serum creatinine <1.5 mg/dL (male) or <1.4 mg/dL (female);
- •7.If female, and of child-bearing potential, has a negative urine pregnancy test at screening and must be using adequate means of contraception as determined by the Investigator;
- •8.Is clinically euthyroid as judged by the Investigator;
- •9.Is able to understand and sign the required study documents and comply with the CIP requirements;
- •10.Is deemed capable by the Investigator to perform the requirements of the CIP, including use of PaQ, frequent self-monitoring of blood glucose.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 15
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •1.Is poorly compliant with the currently prescribed diabetes regimen, as determined by the Investigator;
- •2.Is poorly compliant with prescribed self-monitoring of blood glucose, as determined by the Investigator;
- •3.Is currently taking or has taken sulfonylureas within the last 2 months;
- •4.Has a BMI greater than 40 kg/m2;
- •5.Has experienced recurrent severe hypoglycemia (> 2 episodes) requiring assistance during the past 6 months;
- •6.Has existing dermal irritation/inflammation over the abdominal area that may interfere with use of PaQ, as determined by the Investigator;
- •7.Has known clinically significant hypersensitivity to skin adhesives;
- •8.Is female and if of child-bearing potential, is pregnant, lactating, or planning to become pregnant;
- •9.Is currently being treated with or expected to require or undergo treatment with systemic steroids by oral, intravenous, or intramuscular route (inhaled with low systemic exposure is permitted);
- •10.Currently abuses drugs or alcohol or has a history of abuse that in the Investigator’s opinion would cause the individual to be non-compliant;
- •11.Has received any investigational drug within 1 month;
- •12.Has donated blood within 30 days;
- •13.Has any significant medical condition (including current or past history of cardiovascular disease), laboratory findings, or medical history that in the Investigator’s opinion may affect successful completion of the study and/or personal well-being;
- •14.Is an immediate family member (spouse, parent, child, or sibling) of personnel directly affiliated with the study at the investigative site, or is personally directly affiliated with the study at the investigative site.
研究者
相似试验
招募中
不适用
A single-center, prospective, observational study investigating the levels of insulin antagonist hormones on diabetic ketosis and hyperglycemic emergencies on admissiodiabetes mellitusdiabetic ketosis, diabetic ketoacidosis, hyperosmolar hyperglycemic stateD003920JPRN-jRCT1030200267Suzuki Agena30
已完成
不适用
Examination of the level of insulin antagonist hormones in hyperglycemic emergencies on admission.diabetes mellitusJPRN-UMIN000046105Kitasato University, School of Medicine27
已完成
不适用
Efficacy of Double Carbapenem regimen against Carbapenem resistant Enterobacteriaceae infectionsCTRI/2021/01/030762Roopali Somani46
尚未招募
Unknown
Accuracy of continuous glucose monitoring in cardiac surgeryKCT0009396The Catholic University of Korea, Seoul St. Mary's Hospital42
尚未招募
不适用
Estimating the lacrimal punctum size in an adult populatioacrimal Punctum SizeLacrimal Punctum SizeEye - Diseases / disorders of the eyeACTRN12611000273987Royal Adelaide Hospital100